

Animal-derived Immune Globulin Products Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Animal-derived Immune Globulin Products market is experiencing significant growth, driven by rising demand for therapeutic applications. Market size is projected to reach USD 5.2 billion by 2025, reflecting a compound annual growth rate of 8.1%. Increased focus on animal health and immunization strategies further enhances market prospects and innovation. Request Sample Report
◍ Pfizer
◍ Rare Disease Therapeutics
◍ Instituto Bioclon
◍ Merck & Co
◍ Sanofi
◍ Protherics
◍ Genzyme Corporation
The Animal-derived Immune Globulin Products Market features key players like Pfizer, Rare Disease Therapeutics, Instituto Bioclon, Merck & Co, Sanofi, Protherics, and Genzyme Corporation. These companies enhance market growth through innovative product offerings and strategic partnerships, contributing to advancements in therapeutic applications and expanding treatment options. Sales revenues vary widely among them.
Immunodeficiency
Autoimmune Disease
Acute Infection
Request Sample Report
IVIg Liquid
IVIg Powder
Request Sample Report
$ X Billion USD